OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION H-1B Visa Sponsorship & Salary Data
Yes, OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION sponsors H-1B visas. In FY 2026, OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION filed 3 H-1B labor condition applications (3 certified) with a median salary of $175,000. Across FY 2020–2026, OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION has filed 59 total H-1B applications with 57 certified and a lifetime median salary of $150,000, which is 25% higher than the national H-1B median of $120,000.
FY 2026 Q1: 3 certified LCAs
Certifications dated Oct 1 – Dec 31, 2025 — the first full quarter after the $100K H-1B fee took effect on September 21, 2025.
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION certified 3 H-1B LCAs in FY 2026 Q1 — the first quarter after the $100K H-1B fee took effect on September 21, 2025. The 6-year Q1 baseline (FY 2020–2025) averages 3 certified filings per Q1, so this quarter came in 0% above the historical norm.
Compared to FY 2025 Q1 specifically (1 certified), FY 2026 Q1 is up 200%. The 6-year Q1 range runs from 1 (low) to 5 (peak in FY 2020).
These counts reflect DOL LCA certifications with decision_date in Oct–Dec — a proxy for post-fee sponsorship activity. LCAs do not distinguish cap-subject new hires (fee-exposed) from extensions, transfers, and change-of-status petitions (fee-exempt), so a drop does not cleanly translate to fewer H-1B workers at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION.
Salary Analysis
Salary Range
- 10th percentile: $109,034
- 25th percentile: $127,923
- Median: $150,000
- 75th percentile: $170,000
- 90th percentile: $190,898
Wage Level Distribution
- Level I (Entry): 0 (0%)
- Level II (Qualified): 2 (4%)
- Level III (Experienced): 4 (7%)
- Level IV (Expert): 49 (89%)
Trend (2020-2026)
- Starting median: $122,678
- Current median: $175,000
- Growth: +43%
Salary & Hiring Visualizations
Salary Distribution
Distribution of H-1B salaries at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION's H-1B salaries range from $109,034 to $190,898 (10th-90th percentile), with a median of $150,000. This is 25% above the national H-1B median.
Wage Level Distribution
DOL wage levels affect H-1B lottery priority
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION files 100% of H-1B positions at Level II or higher. Higher wage levels receive priority in the H-1B lottery, giving OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION candidates a competitive advantage.
Median Salary Trend
Year-over-year salary changes
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION's median H-1B salary increased by +43% from FY 2020 ($122,678) to FY 2026 ($175,000). This strong growth reflects competitive compensation adjustments.
H-1B Filings by Year
Annual hiring activity through H-1B program
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION's H-1B filings changed by -63% from FY 2020 to FY 2026. This may reflect changes in hiring strategy or workforce composition.
Salary by Job Title
Top H-1B job titles at this employer
The highest-volume H-1B role at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION is Senior Manager, Statistical Programming with 7 filings at $170,000 median salary.
Salary by Location
Salary distribution across office locations (sorted by median)
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION's largest H-1B hub is Princeton, NJ with 48 filings. The highest-paying location is Aliso Viejo, CA at $180,000 median.
Highest Paying H-1B Roles at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION
Ranked by median salary — Unlike "Salary by Job Title" above which shows the most common roles by filing volume, this section ranks all H-1B positions by their median compensation to highlight the best-paying opportunities.
These are the top 10 highest-paying H-1B job titles at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, ranked by median salary. The highest-paying role is Senior Manager, Statistical Programming at $170,000 median, which is 13% above the company's overall H-1B median of $150,000.
High-paying H-1B roles typically require advanced technical expertise, specialized domain knowledge, or significant leadership responsibility. Factors influencing top-tier compensation include years of experience, educational credentials (PhD, Master's degrees), rare skill combinations, and market demand for specific technologies. The salary distribution chart below each role shows how compensation varies—wider distributions indicate more salary negotiation flexibility, while narrow peaks suggest standardized pay bands. Senior and principal-level positions consistently command premium salaries due to their strategic impact and scarcity of qualified candidates.
Senior Manager, Statistical Programming
7 H-1B filings at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION
Data Analyst
3 H-1B filings at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION
Senior Project Data Manager
3 H-1B filings at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION
Senior Architect
2 H-1B filings at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION
Manager, Regulatory Operations
3 H-1B filings at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION
Sr. Clinical Programmer
2 H-1B filings at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION
Salary data based on 57 certified H-1B labor condition applications at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION. Actual compensation may vary based on experience, specific role requirements, and location within the company.
Highest Individual H-1B Salaries at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION
Actual filed salaries — These are the 10 highest individual H-1B salary filings at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, representing specific positions (not aggregated medians). These may include executive, highly specialized, or senior leadership roles.
The highest H-1B salary filed at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION was $235,000 for a Software Engineer position in Princeton, NJ (FY2025). This is 57% higher than the company's median H-1B salary.
Top H-1B salaries often cluster in high cost-of-living metros like San Francisco, New York, and Seattle where prevailing wages are higher. However, executive and specialized roles can command premium compensation regardless of location. These filings represent the upper bound of H-1B compensation at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION—actual total compensation may be significantly higher when including stock grants, bonuses, and benefits. Geographic patterns in top salaries often reflect where companies locate their most senior technical talent and leadership positions.
Marker size indicates salary level. Click markers for details.
| Rank | Job Title | Location | Salary | Level | Year |
|---|---|---|---|---|---|
| 1 | Software Engineer | Princeton, NJ | $235,000 | IV | FY 2025 |
| 2 | Director, Global Value Evidence Strategy | Princeton, NJ | $215,000 | IV | FY 2024 |
| 3 | Associate Data Engineer | Princeton, NJ | $215,000 | IV | FY 2025 |
| 4 | Director, Safety Data Management | Princeton, NJ | $200,000 | IV | FY 2024 |
| 5 | Associate Physician | Princeton, NJ | $195,000 | IV | FY 2022 |
| 6 | Associate Director, Regulatory Operations | Princeton, NJ | $190,898 | N/A | FY 2026 |
| 7 | Associate Director, Outcomes Research | Princeton, NJ | $185,000 | IV | FY 2021 |
| 8 | Director, Regulatory Affairs | Aliso Viejo, CA | $180,000 | IV | FY 2022 |
| 9 | Senior Manager, Global Safety Data Management | Princeton, NJ | $180,000 | IV | FY 2024 |
| 10 | Associate Director, Safety Data Management | Princeton, NJ | $175,000 | IV | FY 2024 |
These represent the highest individual salary amounts filed in H-1B labor condition applications. Note: H-1B salary data reflects base compensation only and does not include stock options, RSUs, bonuses, or other benefits which can significantly increase total compensation at tech companies.
Detailed Breakdown
H-1B Job Titles at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION
| Job Title | Filings | Median Salary |
|---|---|---|
| Senior Manager, Statistical Programming | 7 | $170,000 |
| Data Analyst | 3 | $170,000 |
| Manager, Regulatory Operations | 3 | $120,000 |
| Senior Project Data Manager | 3 | $160,000 |
| Senior Architect | 2 | $150,000 |
| Sr. Clinical Programmer | 2 | $110,000 |
H-1B Locations for OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION
| Location | Filings | Median Salary |
|---|---|---|
| Princeton, NJ | 48 | $150,000 |
| Rockville, MD | 3 | $160,000 |
| Overland Park, KS | 3 | $158,000 |
| Aliso Viejo, CA | 1 | $180,000 |
| Irving, TX | 1 | $165,000 |
| Waltham, MA | 1 | $140,000 |
Recent H-1B Filings at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION
Sample of 20 recent certified H-1B labor condition applications. This represents a small fraction of OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION's 57 total certified filings.
| Job Title | Location | Salary | Level | Year |
|---|---|---|---|---|
| Associate Director, Regulatory Operations | Princeton, NJ | $190,898 | N/A | FY 2026 |
| Asset Manager | Waltham, MA | $140,000 | III | FY 2026 |
| Senior Manager, Statistical Programming | Princeton, NJ | $175,000 | IV | FY 2026 |
| Associate Data Engineer | Princeton, NJ | $215,000 | IV | FY 2025 |
| Associate Director, Global Quality Operations | Princeton, NJ | $170,000 | IV | FY 2025 |
| Senior Manager, Statistical Programming | Princeton, NJ | $175,000 | IV | FY 2025 |
| Senior Manager, Statistical Programming | Princeton, NJ | $175,000 | IV | FY 2025 |
| Senior Manager, Case Management | Overland Park, KS | $170,000 | IV | FY 2025 |
| Manager, Biostatistics | Princeton, NJ | $145,000 | IV | FY 2025 |
| Data Scientist | Princeton, NJ | $140,000 | IV | FY 2025 |
| Software Engineer | Princeton, NJ | $235,000 | IV | FY 2025 |
| Senior Manager, Case Management (Intake) | Overland Park, KS | $158,000 | IV | FY 2024 |
| Sr. Manager, Statistical Programming | Princeton, NJ | $170,000 | IV | FY 2024 |
| Director, Global Value Evidence Strategy | Princeton, NJ | $215,000 | IV | FY 2024 |
| Manager, Regulatory Operations | Princeton, NJ | $125,000 | IV | FY 2024 |
| Associate Director, Safety Data Management | Princeton, NJ | $175,000 | IV | FY 2024 |
| Senior Manager, Case Management Operations - Intake | Princeton, NJ | $127,923 | IV | FY 2024 |
| Senior Asset Manager | Princeton, NJ | $170,000 | IV | FY 2024 |
| Senior Manager, Statistical Programming | Princeton, NJ | $170,000 | IV | FY 2024 |
| Director, Safety Data Management | Princeton, NJ | $200,000 | IV | FY 2024 |
Data source: U.S. Department of Labor LCA Disclosure Files. Showing most recent certified filings.
Frequently Asked Questions about OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION H-1B Visas
What is the average H-1B salary at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION?
The median H-1B salary at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION is $150,000, based on 57 certified filings from FY 2020 to FY 2026. This is 25% higher than the national H-1B median salary of $120,000. Compensation at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION reflects their market positioning, with entry-level roles starting around $127,923 and senior positions reaching $190,898 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.
Salaries at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION range from $109,034 at the 10th percentile to $190,898 at the 90th percentile, showing a $81,864 spread across experience levels and roles. The 25th percentile is $127,923 and the 75th percentile is $170,000.
Does OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION sponsor H-1B visas in 2026?
Yes, OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION actively sponsors H-1B visas in FY 2026. In the most recent fiscal year (FY 2026), OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION filed 3 H-1B labor condition applications with 3 certified and 0 denied, at a median salary of $175,000. Across FY 2020–2026, they have filed 59 total H-1B applications with 57 certified and a 1.7% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.
In the most recent fiscal year (FY 2026), OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION filed 3 H-1B applications, with 3 certified and 0 denied. Over 7 years of data, OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION has consistently demonstrated commitment to H-1B sponsorship.
Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.
What is OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION's H-1B approval rate?
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION's LCA (Labor Condition Application) denial rate is 1.7%, with 1 out of 59 applications denied across all years. This translates to a 98.3% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION as a potential H-1B sponsor.
This is a good approval rate, comparable to industry averages. OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION demonstrates reliable H-1B sponsorship practices.
What jobs does OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION sponsor for H-1B?
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 57 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION most frequently sponsors can help job seekers target their applications effectively.
Most common H-1B job titles at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION:
The most frequently sponsored role is Senior Manager, Statistical Programming with 7 filings at a median salary of $170,000. This is followed by Data Analyst (3 filings) and Manager, Regulatory Operations.
Where are OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION's H-1B jobs located?
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.
Top OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION H-1B locations:
Circle size indicates relative H-1B filing volume
The largest H-1B hub for OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION is Princeton, NJ with 48 filings at a median salary of $150,000. The highest-paying location is Aliso Viejo, CA at $180,000 median. Salaries range from $140,000 to $180,000 across office locations.
How have OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION's H-1B salaries changed over time?
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION's median H-1B salary has increased by +43% from FY 2020 ($122,678) to FY 2026 ($175,000). Tracking salary trends over time reveals how OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION.
Year-by-year breakdown:
- FY 2022: $141,923 (11 certified)
- FY 2023: $160,000 (6 certified)
- FY 2024: $170,000 (12 certified)
- FY 2025: $175,000 (8 certified)
- FY 2026: $175,000 (3 certified)
This 43% growth reflects strong compensation adjustments at OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, keeping pace with market demands for H-1B talent.
What wage level does OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION use for H-1B?
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION primarily files H-1B applications at Wage Level IV, accounting for 89% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.
With 100% of positions at Level II or higher, OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.
How does OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION's H-1B salary compare to other employers?
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION's median H-1B salary of $150,000 is 25% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION's offerings with similar companies in your field for a more accurate assessment.
This places OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION among the higher-paying H-1B sponsors in the industry. Candidates considering H-1B sponsorship should weigh this competitive compensation alongside other factors like role growth, location, and visa processing track record.
How do new H-1B fees and rules affect OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION's sponsorship?
Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION's higher proportion of Level III-IV positions (96%) may benefit from wage-based lottery prioritization.
With 57 certified filings, OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION invests significantly in H-1B sponsorship. The company's 1.7% denial rate suggests solid H-1B processing practices.
Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.
Companies Similar to OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION
Employers with similar H-1B salary ranges and filing volumes.